本基你就会 求助人 Lv3 关闭了本次求助。

说明 重新填写【积分已退回】

本基你就会 求助人 Lv3 驳回了 JamesPei 上传的文件

说明

Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screening of populations at risk with low-dose CT, the implementation of novel surgical and radiotherapeutic techniques and a deeper biological understanding of NSCLC that has led to innovative systemic treatment options have improved the prognosis of patients with NSCLC. In non-metastatic NSCLC, the combination of various perioperative strategies and adjuvant immunotherapy in locally advanced disease seem to enhance cure rates. In metastatic NSCLC, the implementation of novel drugs might prolong disease control together with preserving quality of life. The further development of predictive clinical and genetic markers will be essential for the next steps in individualized treatment concepts.

回复

JamesPei 首席搬砖师Lv8 上传了文件

已驳回 20241224104842-482835a7-414.pdf (209.73 KB) 回复

科研通AI2.0 机器人 未找到该文献，机器人已退出，请等待人工下载

10:48:39 未找到该文献，机器人已退出，请等待人工下载

10:48:35 科研通AI机器人（澳大利亚 悉尼）收到请求，开始寻找文献

10:48:35 已向机器人发送请求

本基你就会 求助人 Lv3 发起了本次求助